Ocugen (MEX:OCGN) FCF Yield % : -23.25 (As of Apr. 17, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Ocugen FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Ocugen's Trailing 12-Month Free Cash Flow is MXN-847.85 Mil, and Market Cap is MXN3,842.31 Mil. Therefore, Ocugen's FCF Yield % for today is -23.25%.

The historical rank and industry rank for Ocugen's FCF Yield % or its related term are showing as below:

MEX:OCGN' s FCF Yield % Range Over the Past 10 Years
Min: -40571.97 Med: -52.52 Max: -0.67
Current: -23.25

During the past 13 years, the highest FCF Yield % of Ocugen was -0.67%. The lowest was -40571.97%. And the median was -52.52%.

MEX:OCGN's FCF Yield % is ranked worse than
58.88% of 1498 companies
in the Biotechnology industry
Industry Median: -15.34 vs MEX:OCGN: -23.25

Ocugen's FCF Margin % for the quarter that ended in Dec. 2024 was -1,358.22%.

Ocugen FCF Yield % Historical Data

The historical data trend for Ocugen's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocugen FCF Yield % Chart

Ocugen Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Yield %

Get a 7-Day Free Trial

-5.27

-21.84

-47.99

-19.17

Ocugen Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Yield %	Get a 7-Day Free Trial															-37.11	-12.19	-10.99	-15.99	-17.48

Competitive Comparison of Ocugen's FCF Yield %

For the Biotechnology subindustry, Ocugen's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ocugen's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ocugen's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Ocugen's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Ocugen FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Ocugen's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-949.498	/	4953.256
	=	-19.17%

Ocugen's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-216.419	*	4	/	4953.256
	=	-17.48%

Ocugen FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Ocugen FCF Yield % Related Terms

Thank you for viewing the detailed overview of Ocugen's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ocugen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocugen Inc (MEX:OCGN) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

OCGN:USA 2H51:Germany

Address

11 Great Valley Parkway, Malvern, PA, USA, 19355

Website

https://www.ocugen.com

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").